112 related articles for article (PubMed ID: 19692135)
1. Neonatal diabetes in a child positive for islet cell antibodies at onset and Kir6.2 activating mutation.
Gach A; Wyka K; Pietrzak I; Wegner O; Malecki MT; Mlynarski W
Diabetes Res Clin Pract; 2009 Nov; 86(2):e25-7. PubMed ID: 19692135
[TBL] [Abstract][Full Text] [Related]
2. Islet-specific antibody seroconversion in patients with long duration of permanent neonatal diabetes caused by mutations in the KCNJ11 gene.
Gach A; Wyka K; Malecki MT; Noczynska A; Skupien J; Nazim J; Szalecki M; Bodalski J; Sieradzki J; Mlynarski W
Diabetes Care; 2007 Aug; 30(8):2080-2. PubMed ID: 17475937
[No Abstract] [Full Text] [Related]
3. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes.
Massa O; Iafusco D; D'Amato E; Gloyn AL; Hattersley AT; Pasquino B; Tonini G; Dammacco F; Zanette G; Meschi F; Porzio O; Bottazzo G; Crinó A; Lorini R; Cerutti F; Vanelli M; Barbetti F;
Hum Mutat; 2005 Jan; 25(1):22-7. PubMed ID: 15580558
[TBL] [Abstract][Full Text] [Related]
4. Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.
Flechtner I; de Lonlay P; Polak M
Diabetes Metab; 2006 Dec; 32(6):569-80. PubMed ID: 17296510
[TBL] [Abstract][Full Text] [Related]
5. Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.
Bremer AA; Ranadive S; Lustig RH
Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):236-9. PubMed ID: 18221420
[TBL] [Abstract][Full Text] [Related]
6. Clinical profile and etiology of diabetes mellitus with onset at less than 6 months of age.
Valamparampil JJ; Chirakkarot S; Savida P; Omana S
Kaohsiung J Med Sci; 2009 Dec; 25(12):656-62. PubMed ID: 19951851
[TBL] [Abstract][Full Text] [Related]
7. KCNJ11 activating mutations cause both transient and permanent neonatal diabetes mellitus in Cypriot patients.
Ioannou YS; Ellard S; Hattersley A; Skordis N
Pediatr Diabetes; 2011 Mar; 12(2):133-7. PubMed ID: 21352428
[TBL] [Abstract][Full Text] [Related]
8. KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.
Gloyn AL; Diatloff-Zito C; Edghill EL; Bellanné-Chantelot C; Nivot S; Coutant R; Ellard S; Hattersley AT; Robert JJ
Eur J Hum Genet; 2006 Jul; 14(7):824-30. PubMed ID: 16670688
[TBL] [Abstract][Full Text] [Related]
9. Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating [corrected] mutations: evidence for improvement in insulin sensitivity.
Malecki MT; Skupien J; Klupa T; Wanic K; Mlynarski W; Gach A; Solecka I; Sieradzki J
Diabetes Care; 2007 Jan; 30(1):147-9. PubMed ID: 17192350
[No Abstract] [Full Text] [Related]
10. Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutation.
D'Amato E; Tammaro P; Craig TJ; Tosi A; Giorgetti R; Lorini R; Ashcroft FM
Diabet Med; 2008 Jun; 25(6):651-6. PubMed ID: 18544102
[TBL] [Abstract][Full Text] [Related]
11. [Diabetes in infants may be treated with sulfonylurea as a replacement for insulin].
Lauridsen MH; Boesgaard TW; Pedersen OB; Hansen T; Hertz B
Ugeskr Laeger; 2009 Jun; 171(23):1923-4. PubMed ID: 19500515
[TBL] [Abstract][Full Text] [Related]
12. Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM.
Mohamadi A; Clark LM; Lipkin PH; Mahone EM; Wodka EL; Plotnick LP
Pediatr Diabetes; 2010 May; 11(3):203-7. PubMed ID: 19686306
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hyperglycemia in a 7-year-old child diagnosed with neonatal diabetes.
Hathout E; Mace J; Bell GI; Njølstad PR
Diabetes Care; 2006 Jun; 29(6):1458. PubMed ID: 16732049
[No Abstract] [Full Text] [Related]
14. HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months.
Edghill EL; Dix RJ; Flanagan SE; Bingley PJ; Hattersley AT; Ellard S; Gillespie KM
Diabetes; 2006 Jun; 55(6):1895-8. PubMed ID: 16731860
[TBL] [Abstract][Full Text] [Related]
15. Transition from insulin to glyburide in a 4-month-old girl with neonatal diabetes mellitus caused by a mutation in KCNJ11.
Chan YM; Laffel LM
Pediatr Diabetes; 2007 Aug; 8(4):235-8. PubMed ID: 17659066
[TBL] [Abstract][Full Text] [Related]
16. [Glycemic index of meals and postprandial glycemia in patients with permanent neonatal diabetes due to Kir6.2 gene mutations].
Klupa T; Małecki M; Skupień J; Szalecki M; Jałowiec I; Surdej B; Myśliwiec M; Sieradzki J
Przegl Lek; 2007; 64(6):398-400. PubMed ID: 18159846
[TBL] [Abstract][Full Text] [Related]
17. Neonatal diabetes mellitus: description of two Puerto Rican children with KCNJ11 activating gene mutation.
Nieves-Rivera F; González-Pijem L
P R Health Sci J; 2011 Jun; 30(2):87-9. PubMed ID: 21682153
[TBL] [Abstract][Full Text] [Related]
18. Identification of two novel frameshift mutations in the KCNJ11 gene in two Italian patients affected by Congenital Hyperinsulinism of Infancy.
Biagiotti L; Proverbio MC; Bosio L; Gervasi F; Rovida E; Cerioni V; Bove M; Valin PS; Albarello L; Zamproni I; Grassi S; Doglioni C; Mora S; Chiumello G; Biunno I
Exp Mol Pathol; 2007 Aug; 83(1):59-64. PubMed ID: 17316607
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the ABCC8 gene can cause autoantibody-negative insulin-dependent diabetes.
Hartemann-Heurtier A; Simon A; Bellanné-Chantelot C; Reynaud R; Cavé H; Polak M; Vaxillaire M; Grimaldi A
Diabetes Metab; 2009 Jun; 35(3):233-5. PubMed ID: 19342262
[TBL] [Abstract][Full Text] [Related]
20. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
